T. Rowe Price Associates’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$879K Buy
11,233
+941
+9% +$73.6K ﹤0.01% 2042
2025
Q1
$745K Buy
10,292
+988
+11% +$71.5K ﹤0.01% 2088
2024
Q4
$826K Sell
9,304
-5,333
-36% -$473K ﹤0.01% 2046
2024
Q3
$1.24M Buy
14,637
+139
+1% +$11.8K ﹤0.01% 1880
2024
Q2
$1.34M Sell
14,498
-3,242
-18% -$300K ﹤0.01% 1758
2024
Q1
$2M Sell
17,740
-3,072
-15% -$347K ﹤0.01% 1563
2023
Q4
$1.94M Sell
20,812
-5,201
-20% -$485K ﹤0.01% 1549
2023
Q3
$2.39M Sell
26,013
-444
-2% -$40.7K ﹤0.01% 1389
2023
Q2
$3.21M Buy
26,457
+347
+1% +$42.1K ﹤0.01% 1321
2023
Q1
$2.56M Sell
26,110
-2,998
-10% -$294K ﹤0.01% 1381
2022
Q4
$2.36M Sell
29,108
-235,148
-89% -$19.1M ﹤0.01% 1406
2022
Q3
$20.1M Sell
264,256
-979,641
-79% -$74.5M ﹤0.01% 900
2022
Q2
$136M Buy
1,243,897
+1,260
+0.1% +$138K 0.02% 577
2022
Q1
$124M Buy
1,242,637
+3,605
+0.3% +$359K 0.01% 663
2021
Q4
$118M Sell
1,239,032
-47,541
-4% -$4.54M 0.01% 712
2021
Q3
$142M Sell
1,286,573
-1,488
-0.1% -$165K 0.01% 657
2021
Q2
$149M Sell
1,288,061
-12,826
-1% -$1.49M 0.01% 651
2021
Q1
$135M Sell
1,300,887
-13,417
-1% -$1.4M 0.01% 676
2020
Q4
$158M Buy
1,314,304
+30,556
+2% +$3.67M 0.02% 588
2020
Q3
$112M Buy
1,283,748
+27,254
+2% +$2.37M 0.01% 624
2020
Q2
$102M Buy
1,256,494
+58,426
+5% +$4.73M 0.01% 634
2020
Q1
$82.7M Buy
1,198,068
+201,138
+20% +$13.9M 0.01% 628
2019
Q4
$114M Buy
996,930
+18,095
+2% +$2.07M 0.01% 627
2019
Q3
$128M Sell
978,835
-75,478
-7% -$9.85M 0.02% 549
2019
Q2
$129M Buy
1,054,313
+263
+0% +$32.2K 0.02% 579
2019
Q1
$111M Sell
1,054,050
-12,253
-1% -$1.29M 0.02% 610
2018
Q4
$109M Sell
1,066,303
-53,650
-5% -$5.49M 0.02% 583
2018
Q3
$133M Sell
1,119,953
-136,209
-11% -$16.2M 0.02% 592
2018
Q2
$121M Buy
1,256,162
+5,439
+0.4% +$522K 0.02% 609
2018
Q1
$102M Buy
1,250,723
+27,990
+2% +$2.28M 0.02% 644
2017
Q4
$88.3M Sell
1,222,733
-16,182
-1% -$1.17M 0.01% 685
2017
Q3
$76.1M Buy
1,238,915
+26,072
+2% +$1.6M 0.01% 704
2017
Q2
$73.3M Buy
1,212,843
+46,659
+4% +$2.82M 0.01% 698
2017
Q1
$76.2M Buy
1,166,184
+144,969
+14% +$9.47M 0.01% 668
2016
Q4
$71.7M Buy
1,021,215
+711,430
+230% +$49.9M 0.01% 689
2016
Q3
$19.4M Buy
309,785
+28,455
+10% +$1.78M ﹤0.01% 1141
2016
Q2
$16.9M Buy
281,330
+12,300
+5% +$741K ﹤0.01% 1151
2016
Q1
$13.4M Buy
269,030
+10,100
+4% +$502K ﹤0.01% 1200
2015
Q4
$13.9M Buy
258,930
+30,630
+13% +$1.64M ﹤0.01% 1197
2015
Q3
$10.2M Buy
228,300
+90,500
+66% +$4.06M ﹤0.01% 1301
2015
Q2
$7.55M Buy
137,800
+131,400
+2,053% +$7.2M ﹤0.01% 1408
2015
Q1
$304K Hold
6,400
﹤0.01% 2179
2014
Q4
$269K Buy
+6,400
New +$269K ﹤0.01% 2221